Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04949243 · ClinicalTrials.gov registry record
Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 338
- Enrollment target
NCT04949243 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 338 participants.
The verdict
NCT04949243 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 338 participants
- Enrollment target
Study Summary
This observational, cohort sub-studyis embedded within a larger public health intervention that distributes at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communitiesthrough the CDC.Within this sub-study, we will evaluate the socio-behavioral mechanisms of SARS-CoV-2 community transmission, including social interactions, health behaviors, healthcare utilization, knowledge, disease burden, and feasibility of at-home testing. The study hypothesis is that positive at-home test results will be associated withaltered self-reported social interactions and altered health behaviors compared to negative test results. Surveys and questionnaires will be completed by participants through the smartphone app or via call center phone calls according to the schedule of events.Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Interventions
- BEHAVIORAL Behavioral questionaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2021-04-04 |
| Est. Completion | 2021-11-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04949243
The ClinicalTrials.gov registry entry for NCT04949243 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Behavioral questionaires is the first listed.
NCT04949243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04949243 about?
NCT04949243 is a clinical study titled "Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing". This observational, cohort sub-studyis embedded within a larger public health intervention that distributes at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communitiesthrough the CDC.Within this sub-study, we will evaluate the socio-behavioral mechanisms...
What is the current status of trial NCT04949243?
This trial is currently completed. The enrollment target is 338 participants. The study started on 2021-04-04. Estimated completion is 2021-11-23.
What interventions are being tested in trial NCT04949243?
The interventions under investigation include: Behavioral questionaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT04949243?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.